INTERNATIONAL PATENT: MYLAN PHARMACEUTICALS INC. FILES APPLICATION FOR "SOLID ORAL PHARMACEUTICAL COMPOSITIONS INCLUDING CO‑PROCESSED NITROSAMINE INHIBITOR AND MICROCRYSTALLINE CELLULOSE"

GENEVA, June 19 -- MYLAN PHARMACEUTICALS INC. (3711 Collins Ferry RoadMorgantown, West Virginia 26505) filed a patent application (PCT/US2024/058566) for "SOLID ORAL PHARMACEUTICAL COMPOSITIONS INCLUDING CO‑PROCESSED NITROSAMINE INHIBITOR AND MICROCRYSTALLINE CELLULOSE" on Dec 05, 2024. With publication no. WO/2025/122682, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIRSCH, John, D. (3711 Collins Ferry RoadMorgantown, West Virginia 26505), FRIEDMAN, Ross, A. (3711 Collins Ferry RoadMorgantown, West Virginia 2650...